Moderna MRNA shares surged in premarket trading on Wednesday after the company said its mRNA vaccine, when combined with Merck’s Keytruda immunotherapy, delivered positive results in a late-stage…
Moderna MRNA shares surged in premarket trading on Wednesday after the company said its mRNA vaccine, when combined with Merck’s Keytruda immunotherapy, delivered positive results in a late-stage…